Search Login Register

Sympathetic Ophthalmia (Sympathetic Uveitis) Summary

Description: Granulomatous uveitis which follows in one eye after a penetrating injury to the other eye; the secondarily affected eye is called the sympathizing eye, and the injured eye is called the exciting or activating eye.

Also Known As: Sympathetic Uveitis; Ophthalmia, Sympathetic; Ophthalmias, Sympathetic; Sympathetic Ophthalmias; Sympathetic Uveitides Show All >>

Networked: 191 relevant articles (14 outcomes, 11 trials/studies) for this Disease

Key Drugs and Agents for Sympathetic Ophthalmia

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Adrenocorticotropic Hormone (ACTH) : 3 outcomes in 6 results : FDA 7
  2. Cyclosporine (Ciclosporin) : 2 outcomes in 6 results : FDA 20 Generic
  3. Cortisone : 2 outcomes in 6 results : IBA
  4. infliximab (Remicade) : 2 outcomes in 4 results : FDA 2
  5. Anti-Bacterial Agents (Antibiotics) : 2 outcomes in 2 results : IBA
  6. Triamcinolone Acetonide (Azmacort) : 1 outcome 1 study in 4 results : FDA 135 Generic
  7. Chlorambucil (Leukeran) : 1 outcome in 3 results : FDA 1
  8. Penicillins (Penicillin) : 1 outcome in 2 results : FDA 1
  9. Prednisone (Sone) : 1 outcome in 1 result : FDA 119 Generic
  10. Hydrocortisone (Cortisol) : 1 outcome in 1 result : FDA 176 Generic
Show All >>

Diseases Related to Sympathetic Ophthalmia

  1. Wounds and Injuries (Trauma)
  2. Intermediate Uveitis (Chronic Cyclitis)
  3. Retinal Vasculitis
  4. Panuveitis
  5. Body Weight (Weight, Body)
Show All >>

Key Therapies for Sympathetic Ophthalmia

Efficacy Chart >>
  1. Corneal Transplantation (Keratoplasty) : 1 outcome 1 study in 3 results
  2. Plasmapheresis : 1 outcome in 2 results
  3. Immunotherapy : 1 outcome in 1 result
  4. Semiconductor Lasers : 1 study in 3 results
  5. Highly Active Antiretroviral Therapy (HAART) : 1 study in 1 result
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.